WASF2, WASP family member 2, 10163

N. diseases: 95; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders
0.050 GeneticVariation group BEFREE The association between nine SUDs assessed at Wave 1 (2001-2002) and a broad range of outcomes (divorce/separation, violence, unemployment, financial crisis, legal problems, problems with a neighbor, friend, or relative, and quality of life) at Wave 2 (2005-2005) were estimated separately and simultaneously using a latent variable model to account for their co-occurrence and identify potential disorder-specific effects. 31252355 2019
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders
0.050 GeneticVariation group BEFREE Among those in remission from a sedative or tranquilizer use disorder at Wave 1, 4.8% had a tranquilizer or sedative use disorder while 34.7% had at least one other SUD at Wave 2. 29241081 2018
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders
0.050 GeneticVariation group BEFREE US adults with multiple past-year SUDs at Wave 1 were substantially more likely than those with an individual past-year SUD or no SUD at Wave 1 to report at least 1 past-year SUD at Wave 2 (66.3% vs 46.0% vs 6.9%, respectively). 28406266 2017
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders
0.050 Biomarker group BEFREE Conversely, Wave 1 major depressive episodes significantly increased risk of Wave 2 manic episodes (AOR: 2.2; 1.7-2.9) and anxiety disorders (AOR: 1.7; 1.5-2.0), although not substance use disorders (AOR: 1.0; 0.9-1.2). 27137742 2017
CUI: C0038586
Disease: Substance Use Disorders
Substance Use Disorders
0.050 Biomarker group BEFREE In the fully adjusted model, smoking at Wave 2 among Wave 1 nonsmokers was associated with significantly greater odds of SUD relapse compared to Wave 2 nonsmoking (OR = 4.86, 95% CI, 3.11-7.58). 28234432 2017